Gene and cell therapies in China: booming landscape under dual-track regulation

The booming of gene and cell therapy (GCT) worldwide in recent years has been observed, especially in the field of cancers. In order to provide the comprehensive GCT landscape in China with a focus on differential development pathways under the current dual-track regulation mode, we analyzed 953 cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Chen, Gao, Jianchao, Li, Guanqiao, Hu, Hongxi, Zhou, Liyun, Lu, Shuang, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535931/
https://www.ncbi.nlm.nih.gov/pubmed/36199142
http://dx.doi.org/10.1186/s13045-022-01354-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535931/
https://www.ncbi.nlm.nih.gov/pubmed/36199142
http://dx.doi.org/10.1186/s13045-022-01354-9

Ejemplares similares